ClinConnect ClinConnect Logo
Search / Trial NCT04072991

A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)

Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · Aug 27, 2019

Trial Information

Current as of April 24, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Irritable Bowel syndrome - as defined by abdominal pain and altered bowel habit in the absence of organic pathology to explain the symptoms.This is the contemporary definition as provided by the Rome IV committee.
  • 2. Age 18-65 years
  • 3. English literate
  • 4. Can travel to hospital
  • 5. Telephone/internet access
  • Exclusion Criteria:
  • 1. Inflammatory bowel disease
  • 2. Coeliac disease
  • 3. Gastrointestinal cancer
  • 4. Previous abdominal surgery
  • 5. Scleroderma
  • 6. Poorly controlled diabetes
  • 7. Severe liver disease
  • 8. Severe renal disease
  • 9. Severe respiratory disease
  • 10. Severe cardiac disease
  • 11. Severe psychiatric disease
  • 12. Memory disorders
  • 13. Pregnant
  • 14. Current dietary interventions
  • 15. Recent/current use of Probiotics
  • 16. Recent/current use of Antibiotics
  • 17. Recent/current use of Narcotics
  • 18. Currently titrated antidepressants (i.e. not on a stable dose)

Trial Officials

Imran Aziz, MD

Principal Investigator

Sheffield Teaching Hospitals NHS Foundation Trust

About Sheffield Teaching Hospitals Nhs Foundation Trust

Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.

Locations

Sheffield, South Yorkshire, United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials